Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Breder
Christopher Breder, Greenwich, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20090081287 | Pharmaceutical Composition Containing Gelling Agent - Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient. | 03-26-2009 |
| 20100168148 | Pharmaceutical formulation containing gelling agent - Disclosed in certain embodiments is a controlled release oral dosage form comprising a therapeutically effective amount of a drug susceptible to abuse together with one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid; the dosage form providing a therapeutic effect for at least about 12 hours when orally administered to a human patient. | 07-01-2010 |
| 20110230510 | PHARMACEUTICAL FORMULATIONS CONTAINING OPIOID AGONIST, OPIOID ANTAGONIST AND GELLING AGENT - Disclosed in certain embodiments is an oral dosage form comprising a therapeutically effective amount of an opioid analgesic, an opioid antagonist and one or more pharmaceutically acceptable excipients; the dosage form further including a gelling agent in an effective amount to impart a viscosity unsuitable for administration selected from the group consisting of parenteral and nasal administration to a solubilized mixture formed when the dosage form is crushed and mixed with from about 0.5 to about 10 ml of an aqueous liquid. | 09-22-2011 |
Christopher Breder, Greenwhich, CT US
| Patent application number | Description | Published |
|---|---|---|
| 20110256226 | OPIOID AGONIST FORMULATIONS WITH RELEASABLE AND SEQUESTERED ANTAGONIST - Disclosed are oral dosage forms, comprising (i) a therapeutically effective amount of an opioid agonist; (ii) an opioid antagonist in releasable form; and (iii) a sequestered opioid antagonist which is not released when the dosage form is administered intact, and methods thereof. | 10-20-2011 |
Christopher D. Breder, Bethesda, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100069390 | Method of treatment of attention deficit/hyperactivity disorder (ADHD) - The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity. | 03-18-2010 |
| 20100173907 | Method of treatment of aggression - The invention comprises a method of treatment of aggression and similar behavioral syndromes, such as impulsivity and irritability, by a pharmaceutical agent exhibiting combined D2 and D5 antagonistic activity. | 07-08-2010 |
Henrik Breder, Vasteras SE
| Patent application number | Description | Published |
|---|---|---|
| 20100142103 | Compact Secondary Substation Comprising A Fault Protection System, A Method For Fault Protection In A Compact Secondary Substation, And A Control Unit For Performing The Method - A Compact Secondary Substation including a fault protection system and a method for fault protection in Compact Secondary Substations (CSS). The CSS includes a Ring Main Unit (RMU), a transformer and a Low Voltage (LV) switchgear. The CSS includes a number of detectors, which detectors can be placed at least in one of the RMU, the transformer or in the LV switchgear, which detectors can be connected to a control unit, which control unit by fault detection by the detectors can activate a fast operating switch for grounding. By using the fast operating grounding switch and controlling this on the basis of the detectors placed inside the CSS, an active arc fault protection is achieved. The control unit also controls the fast operating grounding switch so that it works as a working grounding switch. | 06-10-2010 |